JESSICA BRIM: Open Payments
NPI 1790867471 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 5 payments from 5 companies in 2025. Trend: 2023 $567 · 2024 $65 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: REZDIFFRA, XIFAXAN, ENTYVIO, SKYRIZI, ZENPEP.
Industry payments across VA — which companies pay providers there.
